Bolt Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 3.81 M | $1.53 M | 0.00% | 9.94% |
| VIVO CAPITAL, LLC | 05/12/2025 | 3.52 M | $1.41 M | 0.00% | 9.18% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2025 | 2.75 M | $1.10 M | 0.00% | 7.18% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 05/14/2025 | 1.89 M | $756.59 K | 0.00% | 4.93% |
| VANGUARD GROUP INC | 05/09/2025 | 1.17 M | $467.88 K | 9.58% | 3.05% |
| NAN FUNG GROUP HOLDINGS LTD | 05/14/2025 | 1.17 M | $466.78 K | 0.00% | 3.04% |
| SAMSARA BIOCAPITAL, LLC | 05/15/2025 | 1.05 M | $419.66 K | 0.00% | 2.74% |
| BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 05/15/2025 | 719.55 K | $287.82 K | 0.00% | 1.88% |
| PFIZER INC | 05/13/2025 | 626.11 K | $250.44 M | 0.00% | 1.63% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 375.11 K | $150.08 K | 10.11% | 0.98% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 314.14 K | $125.66 K | 4.01% | 0.82% |
| BLACKROCK, INC. | 05/02/2025 | 268.64 K | $107.46 K | -0.54% | 0.70% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 244.97 K | $97.99 K | 0.00% | 0.64% |
| SQUAREPOINT OPS LLC | 05/15/2025 | 83.89 K | $33.56 K | 71.31% | 0.22% |
| STATE STREET CORP | 05/15/2025 | 47.44 K | $18.98 K | 0.00% | 0.12% |
| NORTHERN TRUST CORP | 05/13/2025 | 40.90 K | $16.36 K | 0.00% | 0.11% |
| MARINER, LLC | 05/15/2025 | 40.00 K | $16.00 K | 14.29% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 21.73 K | $8.69 K | 100.00% | 0.06% |
| STONEX GROUP INC. | 05/15/2025 | 15.53 K | $6.00 K | 100.00% | 0.04% |
| XTX TOPCO LTD | 05/08/2025 | 15.39 K | $6.16 K | -65.71% | 0.04% |
| MORGAN STANLEY | 05/15/2025 | 11.62 K | $4.65 K | -0.01% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 8.69 K | $3.48 K | 116.77% | 0.02% |
| FMR LLC | 05/12/2025 | 8.10 K | $3.24 K | -93.73% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 5.63 K | $2.25 K | 0.05% | 0.01% |
| JPMORGAN CHASE & CO | 05/12/2025 | 906 | $362 | -0.55% | 0.00% |
| 05/02/2025 | 200 | $80 | 0.00% | 0.00% | |
| SALEM INVESTMENT COUNSELORS INC | 04/16/2025 | 40 | $16 | 0.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/19/2025 | 0 | $0 | -100.00% | 0.00% |
| ENGINEERS GATE MANAGER LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Bolt Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 43 institutional investors and hedge funds held shares of Bolt Biotherapeutics, Inc.. The most heavily invested institutionals were:
TANG CAPITAL MANAGEMENT LLC: 3.81 M
Vivo Capital, LLC: 3.52 M
Sofinnova Investments, Inc.: 2.75 M
Pivotal bioVenture Partners Investment Advisor LLC: 1.89 M
VANGUARD GROUP INC: 1.17 M
Nan Fung Group Holdings Ltd: 1.17 M
47.80% of Bolt Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 19.10 M shares in the last 24 months. This purchase volume represents approximately $6.01 M in transactions.